Novadaq announces third quarter 2007 conference call and webcast

Novadaq Technologies Inc. (TSX: NDQ) develops and commercializes medicalimaging systems and real-time image guided therapies for use in the operatingroom. Novadaq's proprietary ICG imaging systems can be used to visualize bloodvessels, nerves and the lymphatic system during a variety of surgicalprocedures. Novadaq's SPY(R) Imaging System, commercially available worldwide,enables cardiac surgeons to visually assess coronary vasculature and bypassgraft functionality during the course of heart bypass surgery. The SPY Systemis expandable to include upgrade kits for use during other surgeries such asplastic, reconstructive and organ transplant surgery allowing surgeons toevaluate blood flow and tissue and organ perfusion. In addition, SPY is idealfor use during urological procedures enabling surgeons to visualize vessels,tumors, the lymphatic system and potentially nerve bundles. Novadaq's OPTTX(R)System is aimed at the diagnosis, evaluation and treatment of wet Age-relatedMacular Degeneration (AMD) by using the same core imaging technology that isused in the SPY Imaging System. Novadaq also offers the FDA approvedPINPOINT(TM) endoscopic system for visualizing native tissue fluorescencewhich allows surgeons to differentiate between healthy and cancerous tissue inthe lung during thoracic surgery. Novadaq is also the exclusive United Statesdistributor of PLC Medical's CO(2) HEART LASER(TM) System for TMR(Trans-Myocardial Revascularization). For more information, please visit thecompany's website at www.novadaq.com.

Certain statements included in this press release may be consideredforward-looking. Such statements involve known and unknown risks,uncertainties and other factors that may cause actual results, performance orachievements to be materially different from those implied by such statements,and therefore these statements should not be read as guarantees of futureperformance or results. All forward-looking statements are based on Novadaq'scurrent beliefs as well as assumptions made by and information currentlyavailable to Novadaq and relate to, among other things, anticipated financialperformance, business prospects, strategies, regulatory developments, themarket entry (and timing thereof) of additional suppliers of ICG, marketacceptance and future commitments for the PINPOINT endoscopic imaging systemand other Novadaq devices. Readers are cautioned not to place undue relianceon these forward-looking statements, which speak only as of the date of thispress release. Due to risks and uncertainties, including the risks anduncertainties identified by Novadaq in its public securities filings; actualevents may differ materially from current expectations. Novadaq disclaims anyintention or obligation to update or revise any forward-looking statements,whether as a result of new information, future events or otherwise.TORONTO, Oct. 30 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc.(TSX: NDQ), a developer of real-time medical imaging systems and image guidedtherapies for the operating room, will host a conference call and live webcastto discuss the financial results for the third quarter ended September 30,2007. Date: November 5, 2007 Time: 4:30 pm, Eastern Time Dial in number: 416-644-3418 or 1-800-732-6179 Taped replay: 416-640-1917 or 1-877-289-8525 (Available until November 12th, 2007) Code number: 21251726 Webcast: A live audio webcast of the call will be available at www.novadaq.com. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. The webcast will be archived for 90 days. About Novadaq Technologies

SOURCE Novadaq Technologies Inc.

Latest Press Release on General News

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...

Dr. Andres Bustillo Responds to Miami's Growing Interest in Facelift Procedures

In response to the growing demand for facelifts in Miami , Dr. Andres Bustillo , a renowned board-certified facial plastic surgeon, is offering advanced and time-proven techniques in f...

Deepening the Partnership: Dawn Health Introduces Ekiva for Enhanced Disease Management of Paroxysmal Nocturnal Hemoglobinuria (PNH)

COPENHAGEN, Denmark , April 8, 2024 /PRNewswire/ -- Building upon their partnership announced last year, digital health leader Dawn Health and global pharmaceutical company Nov...